(S (S (VP (VBG Selecting) (NP (NP (DT the) (NN right) (NNS drugs)) (PP (IN for) (NP (DT the) (JJ right) (NNS patients)))))) (VP (VBZ is) (NP (NP (DT a) (JJ primary) (NN goal)) (PP (IN of) (NP (NN precision) (NN medicine))))) (. .))
(S (PP (IN In) (NP (DT this) (NN manuscript))) (, ,) (NP (PRP we)) (VP (VBP consider) (NP (NP (DT the) (NN problem)) (PP (IN of) (NP (NN cancer) (NN drug) (NN selection)))) (PP (IN in) (NP (DT a) (JJ learning-to-rank) (NN framework)))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN formulated) (NP (DT the) (NN cancer) (NN drug) (NN selection) (NN problem)) (PP (IN as) (PP (TO to) (S (VP (S (VP (ADVP (RB accurately)) (VBG predicting) (NP (CD 1)))) (-RRB- -RRB-))))))) (. .))
(NP (NP (NP (DT the) (JJ ranking) (NNS positions)) (PP (IN of) (NP (JJ sensitive) (NNS drugs)))) (CC and) (VP (CD 2) (-RRB- -RRB-)) (. .))
(NP (NP (DT the) (JJ ranking) (NNS orders)) (PP (IN among) (NP (NP (JJ sensitive) (NNS drugs)) (PP (IN in) (NP (NN cancer) (NN cell) (NNS lines))))) (PP (VBN based) (PP (IN on) (NP (NP (PRP$ their) (NNS responses)) (PP (TO to) (NP (NN cancer) (NNS drugs)))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (JJ new) (JJ learning-to-rank) (NN method)) (, ,) (VP (VBN denoted) (PP (IN as) (NP (NN pLETORg)))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ predicts) (NP (NP (NN drug) (VBG ranking) (NNS structures)) (PP (IN in) (NP (DT each) (NN cell) (NN line)))) (PP (IN via) (S (VP (VBG using) (NP (NP (NN drug) (NN latent) (NNS vectors)) (CC and) (NP (NN cell) (NN line) (JJ latent) (NNS vectors)))))))))))) (. .))
(S (NP (DT The) (NN pLETORg) (NN method)) (VP (NNS learns) (NP (JJ such) (JJ latent) (NNS vectors)) (PP (IN through) (S (VP (ADVP (RB explicitly)) (VBG enforcing) (SBAR (IN that) (, ,) (S (S (PP (IN in) (NP (NP (DT the) (NN drug) (VBG ranking) (NN list)) (PP (IN of) (NP (DT each) (NN cell) (NN line))))) (, ,) (NP (DT the) (JJ sensitive) (NNS drugs)) (VP (VBP are) (VP (VBN pushed) (PP (IN above) (NP (JJ insensitive) (NNS drugs)))))) (, ,) (CC and) (S (ADVP (RB meanwhile)) (NP (NP (DT the) (JJ ranking) (NNS orders)) (PP (IN among) (NP (JJ sensitive) (NNS drugs)))) (VP (VBP are) (ADJP (JJ correct)))))))))) (. .))
(S (NP (NP (NNS Genomics) (NN information)) (PP (IN on) (NP (NN cell) (NNS lines)))) (VP (VBZ is) (VP (VBN leveraged) (PP (IN in) (S (VP (VBG learning) (NP (DT the) (JJ latent) (NNS vectors))))))) (. .))
(S (NP (NP (PRP$ Our) (JJ experimental) (NNS results)) (PP (IN on) (NP (DT a) (NN benchmark) (NN cell) (JJ line-drug) (NN response) (NN dataset)))) (VP (NN demonstrate) (SBAR (IN that) (S (NP (DT the) (JJ new) (NN pLETORg)) (VP (ADVP (RB significantly)) (VBZ outperforms) (NP (DT the) (JJ state-of-the-art) (NN method)) (PP (IN in) (S (VP (VBG prioritizing) (NP (JJ new) (JJ sensitive) (NNS drugs))))))))) (. .))
